Dear visitor! Welcome to PoreGenic!
Latest update: Recently, our prototype has provided proof of concept with its gigaseal patch clamp analysis of mammalian neuronal networks!
Rationale: PoreGenic's goal is to address a crucial bottle-neck in research, drug discovery and pre-clinical drug development with an Automated Patch Clamp (APC) system for cellular networks. Currently, there are no APC test systems with high throughput capability available that can generate such in vivo-like data.
Applications: PoreGenic identified +15 biopharmaceutical applications that are feasible only with our system: For example, PoreGenic's know-how will allow pharmaceutical companies, CROs and the academic community to screen CNS compounds for their effect on neuronal long-term potentiation, the most fundamental process of neuronal plasticity and learning. This will help fight Alzheimer's, Parkinson's and other neurodegenerative diseases.
Project: The PoreGenic team started to develop its technology in 2009. In 2010, PoreGenic was awarded with the highly respected GO-Bio prize (~ € 3 million) of the BMBF for its chip-based APC approach.
Company: PoreGenic Biosciences GmbH will spin-off from Rostock University in Q2/2014.